---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-032469"
form_type: "8-K"
ticker: "PPCB"
cik: "0001517681"
company_name: "Propanc Biopharma, Inc."
filed_at: "2024-08-15T23:59:59+00:00"
generated_at: "2026-05-31T09:00:17.378119+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Propanc Biopharma issues $33K convertible promissory note to GS Capital at 8% interest

## Summary
- Company entered securities purchase agreement with GS Capital Partners on Aug 9, 2024 for $33,000 principal note at $30,000 purchase price.
- Note matures Feb 2, 2025, bears 8% interest, convertible at $0.0017/share initially, adjustable to $0.001 if stock trades below $0.0014 for 5 days.
- Company can prepay at 110% within 60 days, escalating to 125% after 120 days; no prepayment after 180 days.
- Proceeds used for working capital; note issued under Section 4(a)(2) and Rule 506 of Regulation D.
- Default events include failure to maintain OTC Markets listing, breach of covenants; interest rises to 24% on default.

## SEC filing metadata
- accession: 0001493152-24-032469
- form_type: 8-K
- ticker: PPCB
- cik: 0001517681
- company_name: Propanc Biopharma, Inc.
- filed_at: 2024-08-15T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517681/000149315224032469/0001493152-24-032469-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517681/000149315224032469/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-032469
- JSON: https://secwatch.observer/filing/0001493152-24-032469.json
- Plain text: https://secwatch.observer/filing/0001493152-24-032469.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.